◆英語タイトル:NeoPharm Co Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3593
◆発行会社(調査会社):
MarketLine
◆発行日:2019年12月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:Consumer Packaged Goods
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
MarketLine社の概要はこちらでご確認いただけます。
【レポートの概要】
NeoPharm Co Ltd – Strategy, SWOT and Corporate Finance Report
Summary
NeoPharm Co Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
NeoPharm Co Ltd (NeoPharm) develops, manufactures and markets skin care products. It develops skin care goods primarily for atopic dermatitis and dried skin. The company’s product portfolio includes anti-aging cosmeceuticals and foam wash, soap, shampoo, sun block, soothing creams, soothing lotions, shampoo, soap, foaming cleansers, and sun block for atopic, dry and sensitive skin. NeoPharm’s products are marketed under Zeroid, Atopalm and Derma:B brands. NeoPharm also develops new medicines for treatment of cancer, skin inflammation, asthma, atopic dermatitis and Type II diabetes. In addition, the products and technologies are exported globally. The company has business presence across China, Thailand, Taiwan, Indonesia, Singapore, Hong Kong, Russia, Ukraine, Germany, and the US. NeoPharm is headquartered in DaeJeon, South Korea.
Scope
- Detailed information on NeoPharm Co Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting NeoPharm Co Ltd in the form of a SWOT analysis
- An in-depth view of the business model of NeoPharm Co Ltd including a breakdown and examination of key business segments
- Intelligence on NeoPharm Co Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about NeoPharm Co Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of NeoPharm Co Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess NeoPharm Co Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on NeoPharm Co Ltd’s business structure, strategy and prospects.
Table of Contents
Company Snapshot
Table of Contents
NeoPharm Co Ltd: Company Overview
NeoPharm Co Ltd: Overview and Key Facts
NeoPharm Co Ltd: Overview
NeoPharm Co Ltd: Key Facts
NeoPharm Co Ltd: Key Employees
NeoPharm Co Ltd: Key Employee Biographies
NeoPharm Co Ltd: Major Products and Services
NeoPharm Co Ltd: Company History
NeoPharm Co Ltd: Locations and Subsidiaries
NeoPharm Co Ltd: Key Competitors
NeoPharm Co Ltd: Company Analysis
NeoPharm Co Ltd: Business Description
NeoPharm Co Ltd: SWOT Analysis
NeoPharm Co Ltd: SWOT Overview
NeoPharm Co Ltd: Strengths
NeoPharm Co Ltd: Weaknesses
NeoPharm Co Ltd: Opportunities
NeoPharm Co Ltd: Threats
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: NeoPharm Co Ltd: Key Facts
Table 2: NeoPharm Co Ltd: Key Employees
Table 3: NeoPharm Co Ltd: Company History
Table 4: NeoPharm Co Ltd: Locations and Subsidiaries
Table 5: NeoPharm Co Ltd: Key Competitors